Innovation funding

On January 30, 2024, the Institute for the Hospital Remuneration System (InEK) published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2023. The medical technologies of cardiovascular, ENT, extracorporeal, gastrointestinal, neuromodulation, and other technology groups obtained positive status 1.

On December 15, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions recommending the transfer to standard care for another three completed projects. Two projects evaluated the decision support tools for the BRCA1/2 mutation carriers. The third project analyzed the healthcare provided for patients with congenital heart defects.

On November 14, 2023, the Institute for the Hospital Remuneration System (InEK) published the DRG catalog (Fallpauschalen-Katalog) with the list of DRGs and additional reimbursement categories (ZEs) for 2024.

On October 26, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) reported that 236 applications were received for innovation funding of healthcare research projects.

On October 16, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decision recommending the transfer to standard care for another three completed projects. Two projects evaluated the effects of psychotherapy structural reform. The third project analyzed the health risks of long-term use of proton pump inhibitors (drugs that reduce stomach acid production).

UK patients will benefit from a £30 million government investment in innovative medical technology, which will help ease pressures on the NHS this winter. The Integrated care systems will be able to invest in the latest technology that can help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients.

On September 1, 2023, the Institute for Hospital Remuneration Systems (INeK) announced the start of the application process for the innovation funding of the new examination and treatment methods (NUB) for 2024. The Federal Joint Committee (G-BA) reminds applying hospitals about minor changes in application requirements.

On September 19, 2023, the Innovative Devices Access Pathway (IDAP) pilot was launched. IDAP program aimed to accelerate the development of cost-effective medical devices and their integration into the UK market. The application window to join the pilot phase is now open to the UK and international commercial and non-commercial developers of innovative health technology. The deadline is October 29, 2023. Eight products will be selected for the pilot phase and receive non-financial support from a team of experts.

On September 12, 2023, an application window was opened to join the NHS Innovation Accelerator (NIA) program in 2024. NIA supports the development of individuals (‘Fellows’) and the spread of their innovation nationally. The deadline for applications is October 22, 2023.

In August 2023, NHS England announced the first technology (AposHealth) that will be supported by the MedTech Funding Mandate (MTFM) in 2023/24. MTFM supports NICE-approved, clinically effective, and cost-saving medical devices, diagnostics, and digital technologies, making it mandatory for commissioners and providers to implement them.

On June 30, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for two completed projects. The projects relate to the utilization of emergency care structures in Germany and implementation of patient guidelines for psychosocial therapies for patients with severe mental diseases.

On June 30, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for healthcare research projects (five topics) and clinical guidelines (four topics).